Abstract
TNF receptor (TNFR) superfamily members, CD40, and BAFFR play critical roles in B cell survival and differentiation. Genetic deficiency in a novel adaptor molecule, Act1, for CD40 and BAFF results in a dramatic increase in peripheral B cells, which culminates in lymphadenopathy and splenomegaly, hypergammaglobulinemia, and autoantibodies. While the B cell-specific Act1 knockout mice displayed a similar phenotype with less severity, the pathology of the Act1-deficient mice was mostly blocked in CD40-Act1 and BAFF-Act1 double knockout mice. CD40- and BAFF-mediated survival is significantly increased in Act1-deficent B cells, with stronger IκB phosphorylation, processing of NF-κB2 (p100/p52), and activation of JNK, ERK, and p38 pathways, indicating that Act1 negatively regulates CD40- and BAFF-mediated signaling events. These findings demonstrate that Act1 plays an important role in the homeostasis of B cells by attenuating CD40 and BAFFR signaling.
| Original language | English |
|---|---|
| Pages (from-to) | 575-587 |
| Number of pages | 13 |
| Journal | Immunity |
| Volume | 21 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2004 |
Bibliographical note
Funding Information:This work was supported by National Institutes for Health Grant GM 600020 to X.L.
Funding
This work was supported by National Institutes for Health Grant GM 600020 to X.L.
| Funders | Funder number |
|---|---|
| Foundation for the National Institutes of Health | GM 600020 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Infectious Diseases